Literature DB >> 6168364

Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms.

M Nadji, S Z Tabei, A Castro, T M Chu, G P Murphy, M C Wang, A R Morales.   

Abstract

Antiserum to a human prostate-specific antigen was raised in a rabbit and utilized by immunoperoxidase staining to evaluate its potential value as a diagnostic histologic marker for tumors of prostatic origin. All primary and metastatic prostatic malignancies reacted positively, whereas nonprostatic neoplasms did not stain with this procedure. This is the first immunohistochemical marker for prostate gland epithelium which does not represent prostatic acid phosphatase.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6168364     DOI： 10.1002/1097-0142(19810901)48:5<1229::aid-cncr2820480529>3.0.co;2-l

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  32 in total

1.  Expression of prostate-specific antigen in human prostate specimens in in vitro three-dimensional histoculture.

Authors:  J Geller; L Sionit; K Connors; T Youngkin; R M Hoffman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

2.  Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumors.

Authors:  R R Tremblay; D Deperthes; B Têtu; J Y Dubé
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

3.  Rectal mass of prostatic origin: a possible trap for general surgeons.

Authors:  P R Taylor; P H Rowe; R C Mason; W J Owen
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

Review 4.  Biomarkers for the Management of Castration-Resistant Prostate Cancer: We Are Not There Yet.

Authors:  Daniel P Petrylak; E David Crawford
Journal:  Target Oncol       Date:  2017-08       Impact factor: 4.493

Review 5.  Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.

Authors:  Koh Miura; Kazuyuki Ishida; Wataru Fujibuchi; Akihiro Ito; Hitoshi Niikura; Hitoshi Ogawa; Iwao Sasaki
Journal:  Surg Today       Date:  2012-03-23       Impact factor: 2.549

6.  Diagnosing tumours on routine surgical sections by immunohistochemistry: use of cytokeratin, common leucocyte, and other markers.

Authors:  R N Poston; Y S Sidhu
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

7.  Prostate-specific antigen. Superior serum marker for prostatic carcinoma.

Authors:  J A Heaney; M A Allen; T Keane; M J Duffy
Journal:  Ir J Med Sci       Date:  1987-05       Impact factor: 1.568

8.  Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells.

Authors:  R Riesenberg; R Oberneder; M Kriegmair; M Epp; U Bitzer; A Hofstetter; S Braun; G Riethmüller; K Pantel
Journal:  Histochemistry       Date:  1993-01

9.  Expression of Zn-alpha 2-glycoprotein and PSP-94 in prostatic adenocarcinoma. An immunohistochemical study of 88 cases.

Authors:  S Gagnon; B Têtu; J Y Dubé; R R Tremblay
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

10.  Prostate specific antigen and prostate specific acid phosphatase in adenocarcinoma of Skene's paraurethral glands and ducts.

Authors:  M Zaviacic; J Sidlo; M Borovský
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.